Jump to content

Molecular Computing Patent Application Trends 2025: Difference between revisions

From WikiPatents
Newer edit →
Updating Molecular Computing Patent Application Trends 2025
 
Updating Molecular Computing Patent Application Trends 2025
Line 1: Line 1:
== Molecular Computing Patent Application Filing Activity ==
== Molecular Computing Patent Application Filing Activity ==
== Molecular Computing patent applications in 2025 ==
== Molecular Computing patent applications in 2025 ==
[[File:Molecular_Computing_Monthly_Patent_Applications_2025_-_Up_to_January 2025.png|border|800px]]
[[File:Molecular_Computing_Monthly_Patent_Applications_2025_-_Up_to_February 2025.png|border|800px]]


== Top Technology Areas in Molecular Computing ==
== Top Technology Areas in Molecular Computing ==
[[File:Top_Technology_Areas_in_Molecular_Computing_2025_-_Up_to_January 2025.png|border|800px]]
[[File:Top_Technology_Areas_in_Molecular_Computing_2025_-_Up_to_February 2025.png|border|800px]]


=== Top CPC Codes ===
=== Top CPC Codes ===
* [[:Category:CPC_A61K39/4611|A61K39/4611]] (No explanation available)
* [[:Category:CPC_A61K39/4611|A61K39/4611]] (No explanation available)
** Count: 4 patents
** Count: 5 patents
** Example: [[20250034229. METHODS OF TREATING EGFRVIII EXPRESSING GLIOBLASTOMAS (The Regents of the University of California)]]
** Example: [[20250034229. METHODS OF TREATING EGFRVIII EXPRESSING GLIOBLASTOMAS (The Regents of the University of California)]]
* [[:Category:CPC_A61K39/4631|A61K39/4631]] (No explanation available)
* [[:Category:CPC_A61K39/4631|A61K39/4631]] (No explanation available)
** Count: 4 patents
** Count: 5 patents
** Example: [[20250034229. METHODS OF TREATING EGFRVIII EXPRESSING GLIOBLASTOMAS (The Regents of the University of California)]]
* [[:Category:CPC_C07K14/7051|C07K14/7051]] (No explanation available)
** Count: 3 patents
** Example: [[20250034229. METHODS OF TREATING EGFRVIII EXPRESSING GLIOBLASTOMAS (The Regents of the University of California)]]
** Example: [[20250034229. METHODS OF TREATING EGFRVIII EXPRESSING GLIOBLASTOMAS (The Regents of the University of California)]]
* [[:Category:CPC_A61P35/00|A61P35/00]] (No explanation available)
* [[:Category:CPC_A61P35/00|A61P35/00]] (No explanation available)
** Count: 3 patents
** Count: 3 patents
** Example: [[20250034229. METHODS OF TREATING EGFRVIII EXPRESSING GLIOBLASTOMAS (The Regents of the University of California)]]
* [[:Category:CPC_C07K14/7051|C07K14/7051]] (No explanation available)
** Count: 2 patents
** Example: [[20250034229. METHODS OF TREATING EGFRVIII EXPRESSING GLIOBLASTOMAS (The Regents of the University of California)]]
** Example: [[20250034229. METHODS OF TREATING EGFRVIII EXPRESSING GLIOBLASTOMAS (The Regents of the University of California)]]
* [[:Category:CPC_A61K2239/31|A61K2239/31]] (No explanation available)
* [[:Category:CPC_A61K2239/31|A61K2239/31]] (No explanation available)
Line 25: Line 25:
** Count: 2 patents
** Count: 2 patents
** Example: [[20250034229. METHODS OF TREATING EGFRVIII EXPRESSING GLIOBLASTOMAS (The Regents of the University of California)]]
** Example: [[20250034229. METHODS OF TREATING EGFRVIII EXPRESSING GLIOBLASTOMAS (The Regents of the University of California)]]
* [[:Category:CPC_A61K39/464412|A61K39/464412]] (No explanation available)
** Count: 2 patents
** Example: [[20250034251. ANTIBODY CHEMICALLY INDUCED DIMERIZER (ABCID) AS MOLECULAR SWITCHES FOR REGULATING CELLULAR THERAPIES (The Regents of the University of California)]]
* [[:Category:CPC_C07K2317/92|C07K2317/92]] (No explanation available)
* [[:Category:CPC_C07K2317/92|C07K2317/92]] (No explanation available)
** Count: 2 patents
** Count: 2 patents
** Example: [[20250034251. ANTIBODY CHEMICALLY INDUCED DIMERIZER (ABCID) AS MOLECULAR SWITCHES FOR REGULATING CELLULAR THERAPIES (The Regents of the University of California)]]
** Example: [[20250034251. ANTIBODY CHEMICALLY INDUCED DIMERIZER (ABCID) AS MOLECULAR SWITCHES FOR REGULATING CELLULAR THERAPIES (The Regents of the University of California)]]
* [[:Category:CPC_A61K39/464402|A61K39/464402]] (No explanation available)
* [[:Category:CPC_C07K2319/02|C07K2319/02]] (No explanation available)
** Count: 2 patents
** Example: [[20250034251. ANTIBODY CHEMICALLY INDUCED DIMERIZER (ABCID) AS MOLECULAR SWITCHES FOR REGULATING CELLULAR THERAPIES (The Regents of the University of California)]]
* [[:Category:CPC_C07K2319/03|C07K2319/03]] (No explanation available)
** Count: 2 patents
** Count: 2 patents
** Example: [[20250041416. P329G ANTIBODY TARGETING BCMA, COMBINATION OF SAME WITH CHIMERIC ANTIGEN RECEPTOR CELL, AND USE THEREOF (INNOVENT CELLS PHARMACEUTICALS (SUZHOU) CO., LTD.)]]
** Example: [[20250034251. ANTIBODY CHEMICALLY INDUCED DIMERIZER (ABCID) AS MOLECULAR SWITCHES FOR REGULATING CELLULAR THERAPIES (The Regents of the University of California)]]
* [[:Category:CPC_A61K39/464404|A61K39/464404]] (No explanation available)
** Count: 1 patents
** Example: [[20250034229. METHODS OF TREATING EGFRVIII EXPRESSING GLIOBLASTOMAS (The Regents of the University of California)]]
* [[:Category:CPC_A61K39/464422|A61K39/464422]] (No explanation available)
** Count: 1 patents
** Example: [[20250034229. METHODS OF TREATING EGFRVIII EXPRESSING GLIOBLASTOMAS (The Regents of the University of California)]]


== Top Companies in Molecular Computing 2025 ==
== Top Companies in Molecular Computing 2025 ==
Line 66: Line 66:
* Recent patents:
* Recent patents:
** [[20250042957. DESIGNED REPEAT DOMAINS WITH DUAL BINDING SPECIFICITY AND THEIR USE (Molecular Partners AG)]] (20250206)
** [[20250042957. DESIGNED REPEAT DOMAINS WITH DUAL BINDING SPECIFICITY AND THEIR USE (Molecular Partners AG)]] (20250206)
=== [[:Category:THE GENERAL HOSPITAL CORPORATION|THE GENERAL HOSPITAL CORPORATION]] ===
* Number of Molecular Computing patents: 1
* Top CPC codes:
** [[:Category:CPC_C07K14/4702|C07K14/4702]] (No explanation available): 1 patents
** [[:Category:CPC_A61K39/4611|A61K39/4611]] (No explanation available): 1 patents
** [[:Category:CPC_A61K39/4631|A61K39/4631]] (No explanation available): 1 patents
* Recent patents:
** [[20250074957. MOLECULAR SWITCH-MEDIATED CONTROL OF ENGINEERED CELLS (THE GENERAL HOSPITAL CORPORATION)]] (20250306)
=== [[:Category:PRECIGEN, INC.|PRECIGEN, INC.]] ===
=== [[:Category:PRECIGEN, INC.|PRECIGEN, INC.]] ===
* Number of Molecular Computing patents: 1
* Number of Molecular Computing patents: 1
Line 92: Line 100:


* [[:Category:CPC_C12N2740/15041|C12N2740/15041]] (No explanation available)
* [[:Category:CPC_C12N2740/15041|C12N2740/15041]] (No explanation available)
** Count: 1 patents
** Example: [[20250009801. COMBINATION OF MOLECULAR SWITCH REGULATION TYPE CHIMERIC ANTIGEN RECEPTOR CELL AND ANTIBODY, AND USE THEREOF (INNOVENT CELLS PHARMACEUTICALS (SU ZHOU) CO., LTD.)]]
* [[:Category:CPC_A61K2239/23|A61K2239/23]] (No explanation available)
** Count: 1 patents
** Count: 1 patents
** Example: [[20250009801. COMBINATION OF MOLECULAR SWITCH REGULATION TYPE CHIMERIC ANTIGEN RECEPTOR CELL AND ANTIBODY, AND USE THEREOF (INNOVENT CELLS PHARMACEUTICALS (SU ZHOU) CO., LTD.)]]
** Example: [[20250009801. COMBINATION OF MOLECULAR SWITCH REGULATION TYPE CHIMERIC ANTIGEN RECEPTOR CELL AND ANTIBODY, AND USE THEREOF (INNOVENT CELLS PHARMACEUTICALS (SU ZHOU) CO., LTD.)]]
Line 119: Line 124:
** Example: [[20250009801. COMBINATION OF MOLECULAR SWITCH REGULATION TYPE CHIMERIC ANTIGEN RECEPTOR CELL AND ANTIBODY, AND USE THEREOF (INNOVENT CELLS PHARMACEUTICALS (SU ZHOU) CO., LTD.)]]
** Example: [[20250009801. COMBINATION OF MOLECULAR SWITCH REGULATION TYPE CHIMERIC ANTIGEN RECEPTOR CELL AND ANTIBODY, AND USE THEREOF (INNOVENT CELLS PHARMACEUTICALS (SU ZHOU) CO., LTD.)]]
* [[:Category:CPC_C12Y401/01005|C12Y401/01005]] (No explanation available)
* [[:Category:CPC_C12Y401/01005|C12Y401/01005]] (No explanation available)
** Count: 1 patents
** Example: [[20250027093. MOLECULAR SWITCHES (PRECIGEN, INC.)]]
* [[:Category:CPC_C12Y401/01004|C12Y401/01004]] (No explanation available)
** Count: 1 patents
** Count: 1 patents
** Example: [[20250027093. MOLECULAR SWITCHES (PRECIGEN, INC.)]]
** Example: [[20250027093. MOLECULAR SWITCHES (PRECIGEN, INC.)]]
Line 125: Line 133:
[[File:Top_Companies_in_Emerging_Molecular_Computing_Technologies.png|border|800px]]
[[File:Top_Companies_in_Emerging_Molecular_Computing_Technologies.png|border|800px]]


* [[:Category:INNOVENT CELLS PHARMACEUTICALS (SU ZHOU) CO., LTD.|INNOVENT CELLS PHARMACEUTICALS (SU ZHOU) CO., LTD.]]: 9 patents
* [[:Category:INNOVENT CELLS PHARMACEUTICALS (SU ZHOU) CO., LTD.|INNOVENT CELLS PHARMACEUTICALS (SU ZHOU) CO., LTD.]]: 8 patents
* [[:Category:PRECIGEN, INC.|PRECIGEN, INC.]]: 1 patents
* [[:Category:PRECIGEN, INC.|PRECIGEN, INC.]]: 2 patents


== Top Inventors in Molecular Computing ==
== Top Inventors in Molecular Computing ==
Line 261: Line 269:
* Recent patents:
* Recent patents:
** [[20250042957. DESIGNED REPEAT DOMAINS WITH DUAL BINDING SPECIFICITY AND THEIR USE (Molecular Partners AG)]] (20250206)
** [[20250042957. DESIGNED REPEAT DOMAINS WITH DUAL BINDING SPECIFICITY AND THEIR USE (Molecular Partners AG)]] (20250206)
=== [[:Category:Max Jan|Max Jan of Boston MA (US)]] ===
* Number of Molecular Computing patents: 1
* Top companies:
** [[:Category:THE GENERAL HOSPITAL CORPORATION|THE GENERAL HOSPITAL CORPORATION]]: 1 patents
* Recent patents:
** [[20250074957. MOLECULAR SWITCH-MEDIATED CONTROL OF ENGINEERED CELLS (THE GENERAL HOSPITAL CORPORATION)]] (20250306)
=== [[:Category:Quinlan L. Sievers|Quinlan L. Sievers of Boston MA (US)]] ===
* Number of Molecular Computing patents: 1
* Top companies:
** [[:Category:THE GENERAL HOSPITAL CORPORATION|THE GENERAL HOSPITAL CORPORATION]]: 1 patents
* Recent patents:
** [[20250074957. MOLECULAR SWITCH-MEDIATED CONTROL OF ENGINEERED CELLS (THE GENERAL HOSPITAL CORPORATION)]] (20250306)
=== [[:Category:Benjamin Ebert|Benjamin Ebert of Boston MA (US)]] ===
* Number of Molecular Computing patents: 1
* Top companies:
** [[:Category:THE GENERAL HOSPITAL CORPORATION|THE GENERAL HOSPITAL CORPORATION]]: 1 patents
* Recent patents:
** [[20250074957. MOLECULAR SWITCH-MEDIATED CONTROL OF ENGINEERED CELLS (THE GENERAL HOSPITAL CORPORATION)]] (20250306)
=== [[:Category:Marcela Maus|Marcela Maus of Boston MA (US)]] ===
* Number of Molecular Computing patents: 1
* Top companies:
** [[:Category:THE GENERAL HOSPITAL CORPORATION|THE GENERAL HOSPITAL CORPORATION]]: 1 patents
* Recent patents:
** [[20250074957. MOLECULAR SWITCH-MEDIATED CONTROL OF ENGINEERED CELLS (THE GENERAL HOSPITAL CORPORATION)]] (20250306)
=== [[:Category:Mark Anton HELD|Mark Anton HELD of Germantown MD (US)]] ===
=== [[:Category:Mark Anton HELD|Mark Anton HELD of Germantown MD (US)]] ===
* Number of Molecular Computing patents: 1
* Number of Molecular Computing patents: 1
Line 330: Line 362:
* Germantown: 6 inventors
* Germantown: 6 inventors
* Zürich-Schlieren: 5 inventors
* Zürich-Schlieren: 5 inventors
* Boston: 4 inventors


[[Category:Molecular Computing]]
[[Category:Molecular Computing]]
[[Category:Patent Application Trends by Technology in 2025]]
[[Category:Patent Application Trends by Technology in 2025]]

Revision as of 03:05, 13 March 2025

Molecular Computing Patent Application Filing Activity

Molecular Computing patent applications in 2025

Top Technology Areas in Molecular Computing

Top CPC Codes

Top Companies in Molecular Computing 2025

File:Top Companies in Molecular Computing.png

The Regents of the University of California

INNOVENT CELLS PHARMACEUTICALS (SUZHOU) CO., LTD.

Molecular Partners AG

THE GENERAL HOSPITAL CORPORATION

PRECIGEN, INC.

INNOVENT CELLS PHARMACEUTICALS (SU ZHOU) CO., LTD.

New Companies in Molecular Computing (Last Month)

File:New Companies in Molecular Computing Last Month.png

No new companies detected in the last month.

Emerging Technology Areas in Molecular Computing

Top Companies in Emerging Molecular Computing Technologies 2025

Top Inventors in Molecular Computing

Wei XU

Huafeng WEI

Wendell A. Lim of San Francisco CA (US)

Hideho Okada of San Francisco CA (US)

Kole T. Roybal of San Francisco CA (US)

Joseph H. Choe of San Francisco CA (US)

Payal B. Watchmaker of San Francisco CA (US)

James A. WELLS of San Francisco CA (US)

Zachary B. HILL of San Francisco CA (US)

Alexander J. MARTINKO of San Francisco CA (US)

Diana Binia DAROWSKI

Dan XU

Ying YAO

Bianka PRINZ

Nadthakarn BOLAND

James GEOGHEGAN

Simon Fontaine

Andreas Bosshart

Bernd Schlereth

Daniel Steiner

Marcel Walser

Max Jan of Boston MA (US)

Quinlan L. Sievers of Boston MA (US)

Benjamin Ebert of Boston MA (US)

Marcela Maus of Boston MA (US)

Mark Anton HELD of Germantown MD (US)

Xinhua ZHAO of Germantown MD (US)

Lily Yuin CHAO of Germantown MD (US)

Na TRINH of Germantown MD (US)

James KEALEY of Germantown MD (US)

Kevin Lee DIETZEL of Germantown MD (US)

Shengjie GUO

Jianan CHEN

Guozhi CHEN

Top Collaborations in Molecular Computing

Top US States for Molecular Computing Inventors


Top Cities for Molecular Computing Inventors

  • Suzhou, Jiangsu: 13 inventors
  • San Francisco: 8 inventors
  • Germantown: 6 inventors
  • Zürich-Schlieren: 5 inventors
  • Boston: 4 inventors
Retrieved from "https://wikipatents.org/index.php?title=Molecular_Computing_Patent_Application_Trends_2025&oldid=306611"
Cookies help us deliver our services. By using our services, you agree to our use of cookies.